Skip to content
ReShape Lifesciences Inc. episode artwork

Jul 7, 2020 7 min

ReShape Lifesciences Inc.

from OTCQB Podcast Hosted by OTC Markets Group

ReShape Lifesciences, Inc. (OTCQB: RSLS) develops minimally invasive medical devices that treat obesity and metabolic diseases. With groundbreaking products as the LAP-BAND Adjustable Gastric Banding, ReShape Lifesciences possesses twenty years of reported clinical efficacy. President & CEO, Barton P. Bandy, joins us in this episode to talk about the design and impact of the company's products and its drive to reduce the cost burden associated with the treatment of obesity diseases.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

ReShape Lifesciences Inc.

0:00 7:30

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OTCQB Podcast?

This episode is 7 minutes long.

When was this OTCQB Podcast episode published?

This episode was published on July 7, 2020.

Can I download this OTCQB Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.